Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 2Phase NA 1Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Breast 3Thoracic 1Genitourinary 1CNS 1

Conditions

Prostatic Neoplasms 1751Urinary Bladder Neoplasms 351Carcinoma, Renal Cell 217Breast Neoplasms 209Neoplasms 164Kidney Neoplasms 157Lung Neoplasms 101Colorectal Neoplasms 95Motor Activity 85Testicular Neoplasms 59Ovarian Neoplasms 52Colonic Neoplasms 48Melanoma 47Pancreatic Neoplasms 44Neoplasm Metastasis 43Non-Muscle Invasive Bladder Neoplasms 42Urinary Incontinence 40Head and Neck Neoplasms 40Uterine Cervical Neoplasms 39Carcinoma, Transitional Cell 39Disease 38Urologic Neoplasms 36Sarcoma 36Recurrence 35Anxiety Disorders 31Stomach Neoplasms 29Carcinoma, Non-Small-Cell Lung 29Lymphoma 28Endometrial Neoplasms 28Prostatic Hyperplasia 27

Interventions

Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neoplasm Recurrence, Local × Genitourinary × Clear all
NCT07483658 2026-03-19

HYP-OP-RT

CHU de Quebec-Universite Laval

Phase NA Not yet recruiting
434 enrolled
GastrointestinalGenitourinary

Gastrointestinal Diseases, Neoplasm Recurrence, Local, Prostatic Neoplasms, Radiation Injuries, Urologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡